New drugs for small animals in 2019

摘要

In 2019, 2 novel pharmaceutical agents for small animals were released on the German market: The non-steroidal, non-cyclooxygenase inhibiting anti-inflammatory agent grapiprant (Galliprant(R)) of the piprant class as well as fluorescein (Ophtorescein(R)), a xanthen dye-based diagnostic agent for corneal defects. One substance was authorized for an additional species: The antidiabetic protamine zinc insulin of human origin (ProZinc(R)) is now additionally authorized for dogs. Additionally, one veterinary drug with a new combination of active ingredients (fluralaner + moxidectin), 5 agents in a novel pharmaceutical formulation (acepromazine, chloramphenicol, dexamethasone, metronidazole, torasemide), one drug (lidocaine) with a new route of administration, as well as one agent (apomorphine) in a new primary packaging with extended opening stability have been launched on the market for small animals.